loadpatents
name:-0.005795955657959
name:-0.0048539638519287
name:-0.0004119873046875
Gaudilliere; Bernard Patent Filings

Gaudilliere; Bernard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gaudilliere; Bernard.The latest application filed is for "alkynylated fused ring pyrimidine compounds".

Company Profile
0.8.8
  • Gaudilliere; Bernard - Nanterre FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Alkynylated quinazoline compounds
Grant 6,962,922 - Gaudilliere , et al. November 8, 2
2005-11-08
Alkynylated fused ring pyrimidine compounds
App 20050245548 - Gaudilliere, Bernard ;   et al.
2005-11-03
Oxo-azabicyclic compounds
Grant 6,894,057 - Gaudilliere , et al. May 17, 2
2005-05-17
Triazolo compounds as MMP inhibitors
Grant 6,849,637 - Andrianjara , et al. February 1, 2
2005-02-01
1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV
Grant 6,828,315 - Gaudilliere , et al. December 7, 2
2004-12-07
Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives
Grant 6,787,554 - Gaudilliere September 7, 2
2004-09-07
Thiazine and oxazine derivatives as MMP-13 inhibitors
App 20040006077 - Gaudilliere, Bernard ;   et al.
2004-01-08
Oxo-azabicyclic compounds
App 20030220355 - Gaudilliere, Bernard ;   et al.
2003-11-27
Oxo-azabicyclic compounds
App 20030216402 - Gaudilliere, Bernard ;   et al.
2003-11-20
Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives
App 20030187257 - Gaudilliere, Bernard
2003-10-02
Alkynylated fused ring pyrimidine compounds
App 20030130278 - Gaudilliere, Bernard ;   et al.
2003-07-10
Quinazolines as MMP-13 inhibitors
App 20020193377 - Andrianjara, Charles ;   et al.
2002-12-19
Triazolo compounds as MMP inhibitors
App 20020151558 - Andrianjara, Charles ;   et al.
2002-10-17
Phosphodiesterase 4-inhibiting diazepinoindolones
Grant 6,239,130 - Pascal , et al. May 29, 2
2001-05-29
6-phenyl-3-(piperazinyalalkyl)-2,4(1H,3H)-pyrimidinedione derivatives, their preparation and their application in therapy
Grant 4,950,670 - Frost , et al. August 21, 1
1990-08-21
Therapeutically useful 1-phenyl-2-piperidinoalkanol derivatives
Grant 4,690,931 - Wick , et al. September 1, 1
1987-09-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed